SCHEMBL19783632

SCHEMBL19783632

COc1cc(C(O)c2cccc(C(F)(F)F)c2)c2nc(N)sc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.41
RORB Q92753 3/20 0.41
ALDH1A1 P00352 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP3A4 P08684 2/20 0.38
EPHX2 P34913 1/20 0.38
SCN4A P35499 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAPT P10636 2/20 0.38
POLB P06746 2/20 0.38
HTT P42858 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MDM2 Q00987 1/20 0.38
HKDC1 Q2TB90 1/20 0.38
SAE1 Q9UBE0 1/20 0.38
UBA2 Q9UBT2 1/20 0.38
SCD O00767 1/20 0.36
LMNA P02545 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30189741 1.00 PNMT (0.41) PNMTRORBALDH1A1L3MBTL1CYP3A4
SCHEMBL30189762 0.88 MEN1 (0.39) PNMTALDH1A1L3MBTL1POLBHTT
SCHEMBL19783618 0.88 MEN1 (0.39) PNMTALDH1A1L3MBTL1POLBHTT
SCHEMBL21379367 0.79 CYP3A4 (0.44) ALDH1A1CYP3A4SCN4ATDP1CYP1A2
SCHEMBL30187628 0.76 F2RL3 (0.55)
SCHEMBL19783775 0.76 F2RL3 (0.55)
SCHEMBL19783639 0.76 CYP3A4 (0.43) ALDH1A1L3MBTL1CYP3A4SCN4ATDP1
SCHEMBL30189666 0.76 CYP3A4 (0.43) ALDH1A1L3MBTL1CYP3A4SCN4ATDP1
SCHEMBL21379356 0.74 CYP3A4 (0.41) ALDH1A1CYP3A4EPHX2SCN4ATDP1
SCHEMBL21395379 0.72 GAA (0.42) ALDH1A1L3MBTL1TDP1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-06-03 US disclosed
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BISTOL MYERS SQUIBB COMPANY (US) 2019-09-26 US disclosed
WO-2018013774-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, PF4 PNMT 2833/4885RORB 3734/4885ALDH1A1 1618/4885
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, F12 PNMT 3296/4885RORB 3236/4885ALDH1A1 1598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.